Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy
- PMID: 17699769
- DOI: 10.1158/0008-5472.CAN-06-4353
Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy
Abstract
Tumor hypoxia is commonly observed in primary solid malignancies but the hypoxic status of subclinical micrometastatic disease is largely unknown. The distribution of hypoxia in microscopic tumors was studied in animal models of disseminated peritoneal disease and intradermal (i.d.) growing tumors. Tumors derived from human colorectal adenocarcinoma cell lines HT29 and HCT-8 ranged in size from a few hundred microns to several millimeters in diameter. Hypoxia was detected by immunofluorescent visualization of pimonidazole and the hypoxia-regulated protein carbonic anhydrase 9. Tumor blood perfusion, cellular proliferation, and vascularity were visualized using Hoechst 33342, bromodeoxyuridine, and CD31 staining, respectively. In general, tumors of <1 mm diameter were intensely hypoxic, poorly perfused, and possessed little to no vasculature. Larger tumors (approximately 1-4 mm diameter) were well perfused with widespread vasculature and were not significantly hypoxic. Patterns of hypoxia in disseminated peritoneal tumors and i.d. tumors were similar. Levels of hypoxia in microscopic peritoneal tumors were reduced by carbogen breathing. Peritoneal and i.d. tumor models are suitable for studying hypoxia in microscopic tumors. If the patterns of tumor hypoxia in human patients are similar to those observed in these animal experiments, then the efficacy of systemic treatments of micrometastatic disease may be compromised by hypoxic resistance.
Similar articles
-
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.J Nucl Med. 2010 Apr;51(4):632-8. doi: 10.2967/jnumed.109.071233. J Nucl Med. 2010. PMID: 20351353 Free PMC article.
-
Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors.Cancer Res. 2001 Dec 15;61(24):8903-8. Cancer Res. 2001. PMID: 11751415
-
Identification of nonproliferating but viable hypoxic tumor cells in vivo.Cancer Res. 1998 Aug 15;58(16):3547-50. Cancer Res. 1998. PMID: 9721858
-
Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.Bull Cancer. 2008 Mar;95(3):282-91. doi: 10.1684/bdc.2008.0592. Bull Cancer. 2008. PMID: 18390408 Review.
-
Oxygenation of human tumors: the Mainz experience.Strahlenther Onkol. 1998 Dec;174 Suppl 4:6-12. Strahlenther Onkol. 1998. PMID: 9879340 Review.
Cited by
-
The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten.Gastroenterol Rep (Oxf). 2022 Aug 25;10:goac042. doi: 10.1093/gastro/goac042. eCollection 2022. Gastroenterol Rep (Oxf). 2022. PMID: 36032656 Free PMC article. Review.
-
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.Cancer Chemother Pharmacol. 2012 Jun;69(6):1487-98. doi: 10.1007/s00280-012-1852-8. Epub 2012 Mar 2. Cancer Chemother Pharmacol. 2012. PMID: 22382881 Free PMC article.
-
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.J Clin Invest. 2019 Feb 1;129(2):786-801. doi: 10.1172/JCI97631. Epub 2019 Jan 14. J Clin Invest. 2019. PMID: 30480549 Free PMC article.
-
(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.Transl Oncol. 2014 Apr;7(2):240-7. doi: 10.1016/j.tranon.2014.02.010. Epub 2014 Mar 4. Transl Oncol. 2014. PMID: 24699008 Free PMC article.
-
Animal models of colorectal peritoneal metastasis.Pleura Peritoneum. 2016 Mar 1;1(1):23-43. doi: 10.1515/pp-2016-0006. Epub 2016 Apr 12. Pleura Peritoneum. 2016. PMID: 30911606 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical